|
NCBP2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.3377999819042E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.51600000015173E-08 |
| Normal-vs-Stage2 |
1.015120E-04 |
| Normal-vs-Stage3 |
2.25830000255556E-08 |
| Normal-vs-Stage4 |
3.94449999999713E-05 |
| Stage1-vs-Stage2 |
6.352800E-01 |
| Stage1-vs-Stage3 |
2.162600E-01 |
| Stage1-vs-Stage4 |
8.972600E-01 |
| Stage2-vs-Stage3 |
7.149000E-01 |
| Stage2-vs-Stage4 |
6.209600E-01 |
| Stage3-vs-Stage4 |
3.042800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.27909954534312E-10 |
| Normal-vs-AfricanAmerican |
6.204600E-04 |
| Normal-vs-Asian |
8.614400E-02 |
| Caucasian-vs-AfricanAmerican |
2.104400E-01 |
| Caucasian-vs-Asian |
6.004200E-01 |
| AfricanAmerican-vs-Asian |
9.716600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.97050170519719E-11 |
| Normal-vs-Female |
8.35000000000141E-05 |
| Male-vs-Female |
1.420550E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.984960E-01 |
| Normal-vs-Age(41-60Yrs) |
2.25279999988004E-07 |
| Normal-vs-Age(61-80Yrs) |
1.00480002096504E-09 |
| Normal-vs-Age(81-100Yrs) |
1.89549999995986E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.002200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.549800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.229500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.230650E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.020560E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.573400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.285200E-01 |
| Normal-vs-Grade 2 |
3.1556000001931E-07 |
| Normal-vs-Grade 3 |
5.5786042452155E-11 |
| Normal-vs-Grade 4 |
1.155230E-04 |
| Grade 1-vs-Grade 2 |
1.876220E-01 |
| Grade 1-vs-Grade 3 |
2.282500E-02 |
| Grade 1-vs-Grade 4 |
2.090400E-01 |
| Grade 2-vs-Grade 3 |
3.446500E-02 |
| Grade 2-vs-Grade 4 |
7.141200E-01 |
| Grade 3-vs-Grade 4 |
3.391200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.76020000481381E-08 |
| Normal-vs-ccB subtype |
1.10730000002501E-06 |
| ccA subtype-vs-ccB subtype |
6.246400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.10120000007541E-07 |
| Normal-vs-N1 |
5.375000E-01 |
| N0-vs-N1 |
6.037800E-02 |
|
|
